OrthoGrid Systems and nView medical Partnering Annnounce Partnership

Announced today, nView medical, a leading innovator in 3D medical imaging, and OrthoGrid Systems, a global MedTech leader offering intraoperative alignment technologies, are partnering to provide integrated solutions that increase surgical accuracy and OR efficiency and improve patient outcomes.

As the first step for implementation, the companies are executing a proof of concept for a periacetabular osteotomy (PAO) procedure, and, after completion, will expand to additional musculoskeletal procedures. PAO surgery aims to preserve the hip joint by repositioning the native acetabulum, a complex pediatric joint preservation surgery that aims to reduce or eliminate the risk of a future total hip replacement. OrthoGrid offers the first PAO-specific, imaging-based, surgical navigation application on the market.

“Many problems in orthopedic surgery are 3D problems. Currently, they are solved based on 2D imaging data,” says Dr. Chris Peters, Professor of Orthopaedics at the University of Utah and a renowned hip preservation specialist. “Being able to merge OrthoGrid’s Hip Preservation application with nView’s real-time, 3D, intraoperative imaging data would bring new and valuable information during critical surgical steps, such as the acetabular osteotomy and positioning.”

Both nView medical and OrthoGrid technologies are AI-driven, open platforms designed to work within the surgical theater to improve accuracy, workflow efficiency, and patient outcomes. With the nView 3D imaging data, planning can be achieved intraoperatively, reducing the need for preoperative planning. Similarly, postoperative alignment verification via x-rays may be avoided, and overall radiation exposure to young patients is expected to reduce drastically.

“We are thrilled to engage in this partnership with OrthoGrid, as we truly have aligned company missions: To enhance surgeons’ experience in the OR while simultaneously working to improve patient outcomes,” said Cristian Atria, Founder and CEO at nView Medical. “OrthoGrid’s expert knowledge of procedural steps and intraoperative problem-solving, along with their commitment to AI-driven, imaging-based automation, is an intuitive next step to further expand the opportunity behind real-time, 3D images. We look forward to seeing the immense impact combining these two innovations will have on musculoskeletal procedures in the years to come.”

“This partnership combines two technological needs within intraoperative imaging: Real-time, 3D imaging, and procedural decision making into one unique solution,” said Edouard Saget, Co-Founder, and Co-CEO at OrthoGrid Systems. “We seek to optimize the value equation in orthopedics, one of OrthoGrid’s long-term commitments. By integrating our applications within nView’s 3D imaging system, we are consolidating the number of devices required in the operating room, thus improving operating room efficiency, staff training, and the overall value proposition to the hospital. At the end of the day, we’re always working to make surgeons’ experience in the OR as seamless as possible.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.